/PRNewswire/ Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today announced that its Chief Scientific Officer Dr. Joseph Y. Chang.
/PRNewswire/ Nu Skin Enterprises (NYSE: NUS), a global beauty and wellness leader, today announced that its Chief Scientific Officer Dr. Joseph Y. Chang.
/PRNewswire/ Duality Biotherapeutics, Inc. ("Duality" or "the Company") today announced the appointment of Dr. Antoine Yver as Chairman of SAB. Dr. Antoine.